within Pharmacolibrary.Drugs.ATC.R;

model R03DA20
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 6.666666666666667e-07,
    adminDuration  = 600,
    adminMass      = 240 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0025,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R03DA20</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Combinations of xanthines, such as theophylline with other bronchodilators (for example, etofylline or diprophylline), are used primarily in the management of asthma and chronic obstructive pulmonary disease (COPD) to relax bronchial smooth muscle and relieve bronchospasm. These combinations have been largely replaced by newer agents but may still be used in some countries for specific patient populations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters were estimated based on the combination of theophylline and etofylline in adults after oral administration. Model parameters are adapted from standard theophylline PK studies in adults (mean values in healthy subjects), as no direct publication for the exact combination was found.</p><h4>References</h4><ol><li><p>Ehling, S, et al., &amp; Papich, MG (2019). Diphenhydramine pharmacokinetics after oral and intravenous administration of diphenhydramine and oral administration of dimenhydrinate to healthy dogs, and pharmacodynamic effect on histamine-induced wheal formation: a pilot study. <i>Veterinary dermatology</i> 30(2) 91–e24. DOI:<a href=\"https://doi.org/10.1111/vde.12727\">10.1111/vde.12727</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30779257/\">https://pubmed.ncbi.nlm.nih.gov/30779257</a></p></li><li><p>Weiser, T, &amp; Weigmann, H (2019). Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study. <i>Advances in therapy</i> 36(3) 597–607. DOI:<a href=\"https://doi.org/10.1007/s12325-019-0891-5\">10.1007/s12325-019-0891-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30758744/\">https://pubmed.ncbi.nlm.nih.gov/30758744</a></p></li><li><p>Gillen, M, et al., &amp; Shen, Z (2016). Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers. <i>Drug design, development and therapy</i> 10 3555–3562. DOI:<a href=\"https://doi.org/10.2147/DDDT.S119944\">10.2147/DDDT.S119944</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27843295/\">https://pubmed.ncbi.nlm.nih.gov/27843295</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R03DA20;
